Summary
The only label-supported claim provided is the FDA indication statement for aspirin/extended-release dipyridamole. All other listed statements are not supported by the supplied prescribing information excerpt and include multiple assertions about non-labeled natural products and dosing/effects that are absent from the label.
Category Scores
Accurate Statements
Reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.
1 INDICATIONS AND USAGE: “Aspirin and Extended-Release Dipyridamole Capsule is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.”
Unsupported Statements
Aspirin (acetylsalicylic acid) reduces pain, fever, and inflammation by blocking COX enzymes that produce prostaglandins.
The supplied label excerpt is for stroke-risk reduction indication and does not provide analgesic/antipyretic/anti-inflammatory mechanism statements.
White willow bark contains salicin that the body converts to salicylic acid, aspirin's active metabolite.
Not supported in the provided prescribing information.
White willow bark eases lower back pain.
Not supported in the provided prescribing information.
White willow bark eases osteoarthritis.
Not supported in the provided prescribing information.
White willow bark eases lower back pain and osteoarthritis as effectively as low-dose aspirin or NSAIDs like ibuprofen.
Not supported in the provided prescribing information (and compares efficacy to other products not discussed).
The effects of white willow bark start in 1-2 weeks.
Not supported in the provided prescribing information.
Curcumin inhibits COX-2 and reduces inflammation in arthritis trials.
Not supported in the provided prescribing information.
Turmeric/curcumin matches aspirin's potency for joint pain at 500-2000 mg daily.
Not supported in the provided prescribing information.
Ginger blocks prostaglandins.
Not supported in the provided prescribing information.
Ginger eases menstrual pain.
Not supported in the provided prescribing information.
Ginger eases migraines.
Not supported in the provided prescribing information.
Ginger eases menstrual pain or migraines comparably to aspirin in small RCTs.
Not supported in the provided prescribing information.
White willow acts slower than synthetic aspirin.
Not supported in the provided prescribing information.
White willow avoids stomach irritation from aspirin's acetylation.
Not supported in the provided prescribing information.
White willow dosing is 120-240 mg salicin daily, split.
Not supported in the provided prescribing information.
Aspirin's antiplatelet effect prevents clots at low doses (81 mg).
Not supported in the provided prescribing information excerpt.
White willow has weak anti-clotting in lab tests.
Not supported in the provided prescribing information.
White willow lacks robust heart disease trials.
Not supported in the provided prescribing information.
High doses of white willow risk bleeding like aspirin.
Not supported in the provided prescribing information.
Turmeric mildly thins blood via curcumin.
Not supported in the provided prescribing information.
Turmeric does not match aspirin's cardiovascular outcomes in studies.
Not supported in the provided prescribing information.
No natural option is FDA-approved as a cardioprotective substitute for aspirin.
Not supported in the provided prescribing information.
Physicians advise against swapping for heart conditions.
Not supported in the provided prescribing information.
White willow causes GI upset or ulcers in 5-10% of users.
Not supported in the provided prescribing information.
White willow GI upset or ulcers occur especially with alcohol or NSAIDs.
Not supported in the provided prescribing information.
White willow should be avoided if allergic to aspirin.
While the label contraindicates aspirin/NSAID allergy for aspirin/extended-release dipyridamole, it does not provide guidance about white willow.
Turmeric interacts with blood thinners (e.g., warfarin).
Not supported in the provided prescribing information.
Turmeric may worsen gallbladder issues.
Not supported in the provided prescribing information.
Ginger raises bleeding risk pre-surgery.
Not supported in the provided prescribing information.
All of these are contraindicated in kids/teens due to Reye's syndrome risk from salicylates.
Not supported in the provided prescribing information excerpt.
All are contraindicated in people with peptic ulcers.
The provided label excerpt provides avoidance of aspirin in patients with a history of active peptic ulcer disease, but it does not state contraindications for the listed natural products.
Purity varies among these products.
Not supported in the provided prescribing information.
Standardized extracts tested for heavy metals should be purchased.
Not supported in the provided prescribing information.
Aspirin is faster than natural options.
Not supported in the provided prescribing information.
Aspirin is cheaper (pennies per dose).
Not supported in the provided prescribing information.
Aspirin is proven for acute needs or proven conditions.
Not supported in the provided prescribing information excerpt (label here is for stroke risk reduction).
Aspirin evidence is stronger for pharma aspirin in large trials.
Not supported in the provided prescribing information excerpt as stated.
Contradictions
Low
AI Statement
All are contraindicated in people with peptic ulcers.
Label Reference
5 WARNINGS AND PRECAUTIONS / 5.1 Risk of Bleeding: “Avoid using aspirin in patients with a history of active peptic ulcer disease...”
Important Omissions
Dose and administration guidance for the FDA-approved product (aspirin and extended-release dipyridamole capsule): “one capsule given orally twice daily… Swallow capsules whole without chewing… can be administered with or without food.”
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
The response includes many unsupported recommendations/claims about natural alternatives and contraindications/bleeding/ulcer and pediatric statements not grounded in the provided prescribing information; only the stroke-risk indication claim is supported by the label excerpt.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
Yes |
| Promotes Unapproved Use |
Yes |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Most claims are unrelated to the provided FDA label for aspirin/extended-release dipyridamole (e.g., willow bark, curcumin/turmeric, ginger, dosing, comparative efficacy, and contraindications in kids/teens) and are not supported by the supplied prescribing information.
Suggested Improvement
Limit content to statements supported by the provided prescribing information (indication, contraindications specifically for aspirin/NSAID allergy and asthma/rhinitis/nasal polyps, bleeding risk, avoidance in active peptic ulcer disease for aspirin, alcohol counseling, and any supported administration details). Remove or clearly segregate non-label natural-product claims and unsupported pediatric/contraindication assertions unless supported by the supplied FDA labeling.